| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $653.6M | +42.5% |
| R&D Expense | $138.7M | +116.4% |
| SG&A Expense | $131.3M | +85.0% |
| Operating Income | -$121.0M | -204.7% |
| Interest Expense | $1.3M | +3.7% |
| Pre-tax Income | -$113.0M | -199.6% |
| Income Tax | $1.0M | +0.0% |
| Net Income | -$114.0M | -194.2% |
| EPS (Basic) | -$0.68 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $300.6M | -25.4% |
| Current Assets | $669.4M | +10.2% |
| Total Assets | $696.0M | +11.2% |
| Current Liabilities | $209.1M | +47.7% |
| Total Liabilities | $215.9M | +48.5% |
| Stockholders' Equity | $480.1M | -0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$105.1M | -471.7% |
| Capital Expenditures | $3.7M | +88.1% |
| Investing Cash Flow | -$7.3M | -61.2% |
| Financing Cash Flow | $11.1M | -95.4% |
| Free Cash Flow | -$108.8M | -434.8% |
| -6.3% |
| EPS (Diluted) | -$0.68 | -6.3% |